Skip to main content
All lobbying filings

HOLLAND & KNIGHT LLP

HOLLAND & KNIGHT LLP filed a Q2 report for CONVATEC, INC. F/K/A TRIAD LIFE SCIENCES, INC. on July 13, 2026, reporting $90,000 in lobbying income.

Lobbying for CONVATEC, INC. F/K/A TRIAD LIFE SCIENCES, INC. · Biotechnology

All filings by HOLLAND & KNIGHT LLP · Everything CONVATEC, INC. F/K/A TRIAD LIFE SCIENCES, INC. has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 13, 2026
Income
$90,000
What the client paid this registrant for the period.
Client based in
Tennessee

Official filing document

 Lobbyists on this filing 1
  • LARRY BUCSHON Former member of Congress New on this filing
    Previously held: Member, U.S. House of Representatives

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1

S. 2561 / H.R. 5768 - Medicare coverage of wound care therapies; Skin Substitute Access & Payment Reform Act; H.R. 6852 - Advanced Wound Care and Regenerative Medicine Access and Reform Act; competitive bidding.

 Bills named in this filing 3
  • S. 2561
    Skin Substitute Access and Payment Reform Act of 2025
  • H.R. 5768
    Skin Substitute Access and Payment Reform Act
  • H.R. 6852
    Advanced Wound Care and Regenerative Medicine Access and Reform Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem